CVS Health Corporation $CVS Shares Sold by Waterloo Capital L.P.

Waterloo Capital L.P. lowered its stake in CVS Health Corporation (NYSE:CVS) by 10.0% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 7,266 shares of the pharmacy operator’s stock after selling 808 shares during the period. Waterloo Capital L.P.’s holdings in CVS Health were worth $501,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Goldman Sachs Group Inc. grew its stake in CVS Health by 87.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 9,927,650 shares of the pharmacy operator’s stock worth $672,598,000 after buying an additional 4,632,530 shares during the last quarter. Dodge & Cox grew its holdings in CVS Health by 4.8% during the first quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator’s stock worth $4,976,856,000 after acquiring an additional 3,353,223 shares during the period. Nuveen LLC acquired a new position in CVS Health in the first quarter worth approximately $204,421,000. Invesco Ltd. raised its holdings in CVS Health by 13.2% during the 1st quarter. Invesco Ltd. now owns 20,413,853 shares of the pharmacy operator’s stock worth $1,383,039,000 after buying an additional 2,375,764 shares during the period. Finally, Robeco Institutional Asset Management B.V. boosted its position in shares of CVS Health by 815.2% in the second quarter. Robeco Institutional Asset Management B.V. now owns 2,663,111 shares of the pharmacy operator’s stock worth $183,701,000 after buying an additional 2,372,121 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the stock. Baird R W upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. Piper Sandler lifted their price target on CVS Health from $81.00 to $99.00 in a research report on Friday, October 31st. Wall Street Zen cut CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Truist Financial reiterated a “buy” rating and set a $95.00 target price (up from $92.00) on shares of CVS Health in a research note on Thursday, October 30th. Finally, UBS Group raised their price target on shares of CVS Health from $79.00 to $96.00 and gave the stock a “buy” rating in a research report on Friday, October 24th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $89.41.

CVS Health Stock Performance

NYSE CVS opened at $77.90 on Tuesday. The stock has a market cap of $98.89 billion, a P/E ratio of 205.01, a PEG ratio of 0.87 and a beta of 0.60. The company has a quick ratio of 0.62, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $85.15. The company’s 50-day simple moving average is $78.21 and its 200 day simple moving average is $70.38.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. During the same quarter in the previous year, the company earned $1.09 EPS. The firm’s revenue for the quarter was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio is 700.00%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.